Search

Kareem Batarseh Phones & Addresses

  • Morgantown, WV
  • Fairfax Station, VA
  • Springfield, VA
  • Jefferson, AR
  • Arlington, VA
  • Fairfax Sta, VA
  • Whitmore Lake, MI
  • 8610 Larkview Ln, Fairfax Station, VA 22039

Work

Position: Researcher

Industries

Pharmaceuticals

Resumes

Resumes

Kareem Batarseh Photo 1

Researcher

View page
Location:
8610 Larkview Ln, Fairfax Station, VA 22039
Industry:
Pharmaceuticals
Work:

Researcher

Business Records

Name / Title
Company / Classification
Phones & Addresses
Kareem Batarseh
Novagene LLC
Mfg Pharmaceutical Preparations Noncommercial Research Organization
1209 Macomb St, Morgantown, WV 26501
(304) 319-3334, (703) 967-8720

Publications

Us Patents

Microbicidal Composition Containing Potassium Sodium Tartrate

View page
US Patent:
6630172, Oct 7, 2003
Filed:
Jan 22, 2001
Appl. No.:
09/767035
Inventors:
Kareem I. Batarseh - Fairfax Station VA, 22039
International Classification:
A01N 5502
US Classification:
424618, 424600, 424616, 424617, 424620, 424629, 424630, 424638, 424639, 424641, 424644, 424646, 424649, 424650, 424651, 424652, 424653, 424654, 424655, 424682, 424702, 424722, 424DIG 6, 514184, 514189, 514190, 514191, 514492, 514493, 514494, 514495, 514496, 514497, 514498, 514499, 514500, 514501, 514502, 514503, 514504, 514505, 514635, 514724
Abstract:
Disinfectant formulations are described which are preferably ecologically friendly and non-toxic to mammals and plants, and are highly effective against a broad spectrum of detrimental pathogenic microorganisms. The microbicidal formulation contains complexes having at least one metal ion which is microbicidal to at least one microorganism and potassium sodium tartrate in some form. When potassium sodium tartrate is used with these metal ions, it enhances the complex-forming properties of such metal complexes while concurrently increases their efficacy and potency at the same level of metal ion concentrations. These microbicidal formulations can be diluted in suitable proportions into aqueous systems to produce the desired dosages for each individual case, depending on the level and the severity of the contamination. The microbicidal formulations can be applied by conventional methods, e. g. , spraying, soaking, fogging, impregnation, and the like.

Microbicidal Formulations And Methods To Control Microorganisms

View page
US Patent:
6939566, Sep 6, 2005
Filed:
Jan 17, 2001
Appl. No.:
09/761561
Inventors:
Kareem I. Batarseh - Fairfax Station VA, US
Marwan Al-Kayed - Naur, JO
International Classification:
A01N059/00
A01N033/00
US Classification:
424618, 424613, 424614, 424616, 424617, 424620, 424621, 424622, 424625, 424626, 424627, 424629, 424630, 424638, 424639, 424641, 424644, 424646, 424649, 424650, 424652, 424654, 424655, 424682, 424702, 424DIG 6, 514492, 514493, 514494, 514495, 514497, 514498, 514499, 514500, 514501, 514504, 514505, 514553, 514554, 514557, 514561, 514635, 514706, 514714, 514724
Abstract:
Microbicidal formulations are described which are preferably ecologically friendly and non-toxic to mammals, and are highly effective against a broad spectrum of detrimental pathogenic microorganisms. The microbicidal formulation contains complexes having the formula R-M, wherein R is at least one organic chelating moiety and M is at least one metal ion which is microbicidal to at least one microorganism. These complexes can disrupt microorganism activities by penetrating the natural protecting bio-films of such microorganisms through the reaction of the R-group with the organic constituents of these microorganisms while releasing M into their intra-cellular media. Thus, this process exhibits its biocidal activities from the inside-out, contrary to other methods which rely on damaging the protective biofilms. These microbicidal formulations can be diluted in suitable proportions into aqueous systems to produce the desired dosages for each individual case, depending on the level and the severity of the contamination. The microbicidal formulations can be applied by conventional methods, e. g.

Apoptosis-Inducing Antineoplastic Silver (I) Coordination Complexes

View page
US Patent:
8048870, Nov 1, 2011
Filed:
Sep 13, 2005
Appl. No.:
11/225565
Inventors:
Kareem I. Batarseh - Fairfax Station VA, US
International Classification:
A61K 31/33
US Classification:
514183
Abstract:
The present invention describes chemotherapeutic compositions, a method for making the same, and methods for inducing apoptosis in tumor cells and/or inhibiting tumors. The compositions are metal coordination complexes of a cytotoxic metal, such as silver(I) and a chiral α-organic acid, such as tartaric acid, in a pharmaceutical carrier.

Method Of Treatment And Composition For Inhibiting The Production Of Toxic Free Radical And Reactive Oxygen Species Using Metalloproteins Found In Bacteria

View page
US Patent:
20050267015, Dec 1, 2005
Filed:
May 4, 2005
Appl. No.:
11/121763
Inventors:
Kareem Batarseh - Fairfax Station VA, US
International Classification:
A61K038/16
US Classification:
514006000
Abstract:
Compositions and methods for treating, reducing the risk of, or slowing the onset of a neurological disorder or pathological condition in a subject are provided. An inhibitor of the formation of free radical or reactive oxygen species is administered in an effective amount to the subject and the inhibitor prevents tissue and cellular damage and/or necrosis by inhibiting the release of free radicals or reactive oxygen species (ROS) that can cause such damage in the subject. The inhibitor may be a bacterial metalloprotein. An exemplary free radical production inhibitor is the metalloprotein rusticyanin, a type I blue-copper metalloprotein found in the aerobic acidophilic iron-oxidizing bacterium . A composition containing the inhibitor of the formation of free radical or reactive oxygen species includes a pharmaceutically acceptable carrier.

Chemotherapeutic And Prophylactic Pharmaceutical Compositions

View page
US Patent:
20050276795, Dec 15, 2005
Filed:
Jun 14, 2004
Appl. No.:
10/867214
Inventors:
Kareem Batarseh - Fairfax Station VA, US
International Classification:
A61K038/43
A61K031/28
A61K031/205
A61K033/24
US Classification:
424094100, 424617000, 514492000, 514554000
Abstract:
The present invention provides pharmaceutical compositions and methods for making the same, which are highly effective against cancer, viruses, amoebae, bacteria (both gram-negative and -positive), fungi, algae, bacterial spores, yeast, and the like. The compounds preferably rely on employing the synergistic effect of organo-metal compounds and the concomitant generation of reactive oxygen species (ROS) through the agency of reducing cofactors. The aqueous solution may be condensed and dried using conventional methods available to those skilled in the art to produce gels as well as solids, such as tablets or powders. Solid forms include tablets, capsules, suppositories, and the like or mixtures thereof. In addition, the solid form of the present compositions may be activated upon solubilization in a liquid.

Microbicidal Formulations And Methods To Control Microorganisms

View page
US Patent:
62420097, Jun 5, 2001
Filed:
Apr 20, 1999
Appl. No.:
9/294143
Inventors:
Kareem I. Batarseh - Morgantown WV
Marwan Al-Kayed - Naour, Amman, JO
International Classification:
A01N 5900
A01N 3300
US Classification:
424618
Abstract:
Microbicidal formulations are described which are preferably ecologically friendly and non-toxic to mammals, and are highly effective against a broad spectrum of detrimental pathogenic microorganisms. The microbicidal formulation contains complexes having the formula R-M, wherein R is at least one organic chelating moiety and M is at least one metal ion which is microbicidal to at least one microorganism. These complexes can disrupt microorganism activities by penetrating the natural protecting bio-films of such microorganisms through the reaction of the R-group with the organic constituents of these microorganisms while releasing M into their intra-cellular media. Thus, this process exhibits its biocidal activities from the inside-out, contrary to other methods which rely on damaging the protective biofilms. These microbicidal formulations can be diluted in suitable proportions into aqueous systems to produce the desired dosages for each individual case, depending on the level and the severity of the contamination. The microbicidal formulations can be applied by conventional methods, e. g.

Methods To Prevent And Treat Acid Mine Drainage And To Remove Metals And Non-Metals From Aqueous Sources

View page
US Patent:
56162510, Apr 1, 1997
Filed:
Nov 20, 1995
Appl. No.:
8/561182
Inventors:
Kareem I. Batarseh - Morgantown WV
International Classification:
C02F 162
US Classification:
210725
Abstract:
The present invention is directed to the use of water-soluble compositions containing a compound having a Lewis base group attached to a hydrophobic group where the Lewis base group is capable of donating at least one lone pair of electrons to a metal. These compositions are effective in treating acid mine drainage by treating the source of the acid mine drainage as well as the acid mine drainage waters. These compositions are also effective in removing metal and non-metal ions from aqueous sources and the process can be modified to allow the selective removal of metal and non-metal ions from aqueous sources.

Children Blood Transfusion And Thymus Hormonal Therapy As Antiviral And Antibacterial Compounds

View page
US Patent:
20210330706, Oct 28, 2021
Filed:
Mar 5, 2021
Appl. No.:
17/300085
Inventors:
Kareem Issa Batarseh - Fairfax Station VA, US
International Classification:
A61K 35/16
A61K 38/22
A61K 38/32
A61K 38/08
A61K 45/06
Abstract:
The present invention describes compounds that are safe, nontoxic, noncorrosive, and nonirritating and methods thereof that are antibacterial and antiviral (encompassing cancer as well or chemotherapy) for the prevention and treatment of individuals suffering from infectious diseases. The compounds of the instant invention can also be administered to those individuals who are in need of such therapy such as those who have thymus diseases or those who are old enough that the thymus gland does not function anymore (thymus involution). This method can also be employed in healthy subjects as a preventive measure against such infections. The method relies on administering to infected patient healthy whole blood or healthy plasma transfusion procured from healthy children where it is permissible by law (emphasis added) or from healthy adults ages 18 to 20 years. This as a result will endogenously regenerate the thymus gland via the process of thymopoiesis to produce mature T cells, which are the most important cells in adaptive immunity for combating bacterial and viral infections. The compounds of the instant invention can be those, but not limited to, hormones secreted by the thymus gland and their synthetic counterparts, a combination of them, their active compounds, their progenitors, and their stimulating and mediated compounds and their mixtures thereof all can be used in the instant invention.
Kareem Issa Batarseh from Morgantown, WV, age ~62 Get Report